Trump meets Zelenskiy, says Putin wants war to end, mulls trilateral talks
LEHI, Utah - Nature’s Sunshine Products, Inc. (NASDAQ:NATR), a prominent manufacturer of herbal and nutritional supplements with a market capitalization of $283.7 million, today announced the impending departure of Terrence Moorehead as President and CEO, effective upon the appointment of his successor. Moorehead has also decided to resign from the Board of Directors once a new leader is in place.
The company’s board has commenced a comprehensive search for the next President and CEO, engaging a nationally recognized executive search firm to assist in the process. Moorehead, who has been at the helm since 2018, expressed pride in the company’s advancements under his leadership, particularly in strengthening the brand and driving customer growth through digital initiatives. According to InvestingPro data, the company maintains impressive gross profit margins of 71.68% and strong financial health, with more cash than debt on its balance sheet.
Heidi Wissmiller, Chairman of the Board, acknowledged Moorehead’s contributions, particularly during times of global uncertainty, and credited him with laying a solid foundation for the company’s future growth. She underscored the company’s readiness to accelerate its transition towards a digitally enabled organization and omnichannel business model.
In conjunction with today’s announcement, Nature’s Sunshine reaffirmed its full-year 2025 financial outlook for net sales and adjusted EBITDA, maintaining the guidance previously set forth. InvestingPro analysis indicates the company is currently undervalued, with analysts maintaining a strong buy consensus and projecting profit growth for the year. For detailed valuation metrics and additional insights, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.
Nature’s Sunshine is recognized for marketing and distributing its products across more than 40 countries, with a commitment to high-quality, safety, and efficacy standards, upheld by manufacturing most of its products in its own facilities.
The company’s forward-looking statements in the press release are subject to risks and uncertainties, including potential delays or challenges in finding a new CEO and the impact of leadership transition on business expectations. These statements are based on current projections and experiences, with cautionary notes that actual future results may differ from current predictions. The company maintains a healthy liquidity position with a current ratio of 2.41, providing some financial flexibility during this transition period.
This news article is based on a press release statement from Nature’s Sunshine Products, Inc.
In other recent news, Nature’s Sunshine Products reported a strong start to 2025 with first-quarter earnings surpassing expectations. The company achieved an earnings per share (EPS) of $0.25, significantly above the forecasted $0.17, and revenue reached $113.2 million, exceeding the anticipated $109.42 million. This financial performance reflects a 5% increase in revenue on a constant currency basis, driven by robust sales growth in Asia Pacific and Europe. Nature’s Sunshine also announced a $25 million share repurchase program, indicating management’s confidence in the company’s future prospects. DA Davidson resumed coverage on Nature’s Sunshine with a Buy rating, although the price target was adjusted to $19 from the previous $23.50. The analyst noted the company’s solid financial position and the potential for positive future performance. Nature’s Sunshine maintains a strong balance sheet with zero debt and $86.5 million in cash, which supports its strategic initiatives and operational efficiency. The company remains cautious due to macroeconomic uncertainties and potential tariff impacts but anticipates continued growth, especially in North America.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.